SOMAÍ signs UK agreement to launch cannabis brands

Cannabis operator SOMAÍ enters UK market through brand agreement as medical sector expands.

FILE — retail · My 420 Tours / CC BY-SA 4.0

SOMAÍ has signed an agreement to launch cannabis brands in the UK, according to MMJDaily. The move reflects growing commercial interest in a market projected to exceed 140,000 patients by 2026, per Newsweed analysis. It follows other recent entry attempts by larger operators—Curaleaf Laboratories launched medical cannabis suppositories in the UK in May, and European partnerships have accelerated among North American cultivators including Seed Junky Genetics.

The agreement signals confidence in the UK's regulated medical framework, though the sector remains nascent and subject to licensing constraints. No license records for SOMAÍ appear in official UK registers, suggesting the brands may operate under existing licensee infrastructure or pending regulatory approval. Illicit smuggling attempts—including 247 pounds seized in April and a $2.4M shipment intercepted in January—underscore the tension between legal market development and underground competition.

Watch whether SOMAÍ's brands launch under an existing licensed producer or require separate regulatory approval, which could indicate the pace at which the UK medical cannabis licensing process accommodates new entrants.